A detailed history of Riverwater Partners LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Riverwater Partners LLC holds 5,643 shares of CRL stock, worth $1.09 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
5,643
Previous 5,517 2.28%
Holding current value
$1.09 Million
Previous $1.14 Million 2.46%
% of portfolio
0.61%
Previous 0.96%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$187.96 - $245.29 $23,682 - $30,906
126 Added 2.28%
5,643 $1.11 Million
Q2 2024

Jul 19, 2024

BUY
$206.39 - $268.73 $387,600 - $504,674
1,878 Added 51.61%
5,517 $1.14 Million
Q1 2024

Apr 18, 2024

BUY
$203.52 - $273.43 $6,512 - $8,749
32 Added 0.89%
3,639 $985,000
Q4 2023

Jan 04, 2024

BUY
$164.52 - $238.84 $3,948 - $5,732
24 Added 0.67%
3,607 $852,000
Q3 2023

Oct 18, 2023

SELL
$194.44 - $217.61 $8,166 - $9,139
-42 Reduced 1.16%
3,583 $702,000
Q2 2023

Jul 18, 2023

BUY
$183.71 - $210.25 $31,414 - $35,952
171 Added 4.95%
3,625 $762,000
Q1 2023

Apr 12, 2023

BUY
$191.89 - $259.92 $3,645 - $4,938
19 Added 0.55%
3,454 $697,000
Q4 2022

Jan 12, 2023

BUY
$197.11 - $250.07 $25,624 - $32,509
130 Added 3.93%
3,435 $0
Q3 2022

Nov 08, 2022

BUY
$182.44 - $250.54 $224,766 - $308,665
1,232 Added 59.43%
3,305 $650,000
Q2 2022

Aug 05, 2022

BUY
$204.13 - $302.4 $32,048 - $47,476
157 Added 8.19%
2,073 $444,000
Q1 2022

May 02, 2022

SELL
$255.51 - $362.11 $485,469 - $688,009
-1,900 Reduced 49.79%
1,916 $544,000
Q4 2021

Jan 31, 2022

BUY
$351.38 - $448.68 $1.34 Million - $1.71 Million
3,816 New
3,816 $1.44 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Riverwater Partners LLC Portfolio

Follow Riverwater Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverwater Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverwater Partners LLC with notifications on news.